Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation

Journal of the American Veterinary Medical Association

Volumn 221, Issue 5, 2002, Pages 654-658

  Atkins, Clarke E ^a   Brown, William A ^b   Coats, Julie R ^a   Crawford, Mary Ann ^c   Defrancesco, Teresa C ^a   Edwards, Joel ^d   Fox, Philip R ^e   Keene, Bruce W ^a   Lehmkuhl, Linda ^f,j   Luethy, Michael ^g   Meurs, Kate ^f   Petrie, Jean Paul ^e   Pipers, Frank ^h,l   Rosenthal, Steven ⁱ   Sidley, Jennifer A ^a,i   Straus, Justin ^c,k  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Veterinary Cardiology Consults   (United States)

^c Oradell Animal Hospital   (United States)

^d Albany County Veterinary Hospital   (United States)

^e ANIMAL MEDICAL CENTER   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g Cardioscope Pet Referral Service   (United States)

^h BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

ⁱ Chesapeake Veterinary Referral Center   (United States)

^j MedVet Specialty Clinic   (United States)

^k Animal Emergency and Referral Center   (United States)

^l Dove Lewis Emergency Animal Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENALAPRIL; NITROGEN; PLACEBO; UREA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; FOLLOW UP; KIDNEY FUNCTION; LONG TERM CARE; MITRAL VALVE REGURGITATION; NONHUMAN; UREA BLOOD LEVEL; UREMIA; ANIMAL; ANIMAL DISEASE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOG; DOG DISEASE; FEMALE; KIDNEY; KIDNEY FUNCTION TEST; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; UREA NITROGEN BLOOD LEVEL;

ANIMALIA; CANIS FAMILIARIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD UREA NITROGEN; CREATININE; DOG DISEASES; DOGS; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MITRAL VALVE INSUFFICIENCY; TIME FACTORS;

EID: 0036708410     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.221.654     Document Type: Article

References (22)

1. Effects of enalapril on mortality in severe congestive heart failure: Results of the cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
3. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
4. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
5. Angiotensin-converting enzyme inhibitors
6. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally occurring acquired heart failure: Results of the invasive multicenter prospective veterinary evaluation of enalapril study
7. Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the cooperative veterinary enalapril study group
8. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure
9. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial
10. Renal effects of enalapril in dogs
11. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe, chronic, heart failure
12. Potential adverse effects of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure
13. The effect of combined therapy with captopril, furosemide, and a sodium-restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure
14. Evaluation of renal function
15. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine
16. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results of the studies of left ventricular dysfunction (SOLVD)
17. Correlates and impact on outcomes of worsening renal function in patients 65 years of age with heart failure
18. Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors
19. Effect of the angiotensin-converting enzyme-inhibitor benazepril on the progression of chronic renal failure
20. Effect of enalapril on mortality and development of heart failure in patients with reduced left ventricular function
21. Activation of reninangiotensin-aldosterone system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency